Clinical Trials Directory

Trials / Terminated

TerminatedNCT00123188

Ultrasound and Endometrial Hyperplasia

Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Milton S. Hershey Medical Center · Academic / Other
Sex
Female
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that endometrial thickness will be a significant predictor of endometrial hyperplasia in a postmenopausal female population with metabolic syndrome: diabetes and/or insulin resistance, hypertension, and obesity.

Detailed description

The objective is to identify the utility of ultrasound as a screening test for endometrial hyperplasia and cancer in an "at risk" cohort. Endometrial carcinoma is an understudied cancer. This study will provide benefit regardless of its outcome, because it will be the first prospectively designed screening trial in an asymptomatic population.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound and BiopsyTransvaginal ultrasound and Endometrial Biopsy

Timeline

Start date
2005-04-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2005-07-22
Last updated
2015-01-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00123188. Inclusion in this directory is not an endorsement.